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Vaccination complacency occurs when perceived risks of vaccine-preventable diseases are
sufficiently low so that vaccination is no longer perceived as a necessary precaution. Dis-
ease outbreaks can once again increase perceptions of risk, thereby decrease vaccine com-
placency, and in turn decrease vaccine hesitancy. It is not well understood, however, how
change in perceived risk translates into change in vaccine hesitancy.
We advance the concept of vaccine propensity, which relates a change in willingness to
vaccinate with a change in perceived risk of infection—holding fixed other considerations
such as vaccine confidence and convenience.
Methods and findings
We used an original survey instrument that presents 7 vaccine-preventable “new” diseases
to gather demographically diverse sample data from the United States in 2018 (N = 2,411).
Our survey was conducted online between January 25, 2018, and February 2, 2018, and
was structured in 3 parts. First, we collected information concerning the places participants
live and visit in a typical week. Second, participants were presented with one of 7 hypotheti-
cal disease outbreaks and asked how they would respond. Third, we collected sociodemo-
graphic information. The survey was designed to match population parameters in the US on
5 major dimensions: age, sex, income, race, and census region. We also were able to
closely match education. The aggregate demographic details for study participants were a
mean age of 43.80 years, 47% male and 53% female, 38.5% with a college degree, and
24% nonwhite. We found an overall change of at least 30% in proportion willing to vaccinate
as risk of infection increases. When considering morbidity information, the proportion willing
to vaccinate went from 0.476 (0.449–0.503) at 0 local cases of disease to 0.871 (0.852–
0.888) at 100 local cases (upper and lower 95% confidence intervals). When considering
mortality information, the proportion went from 0.526 (0.494–0.557) at 0 local cases of dis-
ease to 0.916 (0.897–0.931) at 100 local cases. In addition, we ffound that the risk of mortal-
ity invokes a larger proportion willing to vaccinate than mere morbidity (P = 0.0002), that
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older populations are more willing than younger (P<0.0001), that the highest income bracket
(>$90,000) is more willing than all others (P = 0.0001), that men are more willing than
women (P = 0.0011), and that the proportion willing to vaccinate is related to both ideology
and the level of risk (P = 0.004). Limitations of this study include that it does not consider
how other factors (such as social influence) interact with local case counts in people’s vac-
cine decision-making, it cannot determine whether different degrees of severity in morbidity
or mortality failed to be statistically significant because of survey design or because partici-
pants use heuristically driven decision-making that glosses over degrees, and the study
does not capture the part of the US that is not online.
Conclusions
In this study, we found that different degrees of risk (in terms of local cases of disease) cor-
respond with different proportions of populations willing to vaccinate. We also identified sev-
eral sociodemographic aspects of vaccine propensity.
Understanding how vaccine propensity is affected by sociodemographic factors is invalu-
able for predicting where outbreaks are more likely to occur and their expected size, even
with the resulting cascade of changing vaccination rates and the respective feedback on
potential outbreaks.
Author summary
Why was this study done?
• In the US, vaccine-preventable diseases have gone down (~1970–2000s), followed by a
rise in vaccine hesitancy (~2000–2018).
• In places where disease outbreaks have occurred, vaccination rates have gone back up
(~2000–2018).
• We conducted this survey to better understand how local cases of disease can influence
people to vaccinate.
What did the researchers do and find?
• We conducted a survey that presented participants with one of 7 new disease outbreaks,
each with a different degree of morbidity or mortality.
• We asked participants how many local case counts it would take for them to vaccinate
against that disease.
• The risk of mortality was associated with greater willingness to vaccinate in the presence
of fewer case counts compared to the risk of morbidity.
• Likewise, older populations were more willing than younger, people with high incomes
were more willing than all income levels, men were more willing than women, and our
findings suggest a relationship between willingness to vaccinate and political ideology.
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What do these findings mean?
• Part of people’s decision to vaccinate is their risk of contracting the disease, and this
assessment can vary across different populations.
• This information can be helpful for campaigns that aim to reduce vaccine hesitancy and
is useful for modeling feedback between human decision-making and the spread of
disease.
Introduction
In order to understand the recent decline in vaccination rates and the increase of nonmedical
vaccine exemptions, research on the formation of vaccine attitudes has been on the rise [1].
“Vaccine hesitancy” is an important concept that has emerged out of this research and unifies
several considerations. Vaccine hesitancy is understood as the delay in acceptance or refusal of
vaccination despite the availability of vaccination services [2]. More specifically, it encom-
passes 3 factors that contribute to the complex decision-making process for vaccination: com-
placency, confidence, and convenience.
Vaccination complacency occurs when the perceived risks of vaccine-preventable diseases
are sufficiently low so that vaccination is no longer perceived as a necessary precaution. For
example, after the first measles vaccine was licensed in 1963, the number of reported cases in
the US dwindled from the hundreds of thousands per year to about 1,000–10,000 per year by
the 1980s, to fewer than 1,000 per year by the year 2000, when it was declared eliminated [3].
Without the threat of contracting measles, and similarly other vaccine-preventable diseases,
the success of vaccination programs decreases the incentive to vaccinate, thereby providing
room for complacency and, consequently, vaccine hesitancy. Furthermore, a decrease in vac-
cine confidence and lack of convenience can further exacerbate vaccine hesitancy.
Evidence of increased vaccine hesitancy in the US can be seen in the rise of nonmedical vac-
cine exemptions and, relatedly, a decrease in vaccination rates [4]. In order to combat drop-
ping vaccination, some states, e.g., California and Washington, have instituted policies that
prohibit nonmedical exemptions. It is expected that such changes in policies will help increase
vaccination rates. Of course, such policies may change in the future. Furthermore, many states
in the US have not adopted such a strategy and continue to allow for nonmedical exemptions.
Currently, 18 states allow nonmedical exemptions [4].
Even without institutional changes, however, there is evidence that suggests that disease
outbreaks can once again increase perceptions of risk, thereby decrease vaccine complacency,
and in turn decrease vaccine hesitancy. For example, following a measles outbreak of more
than 16,000 cases and 75 deaths in California from 1988 to 1990, Dales and colleagues [5]
found that the strongest vaccination response occurred where media coverage was highest and
that the response decayed with both time and distance [6–8]. Similarly for pertussis: when a
county in the US experienced a large pertussis outbreak, the proportion of unvaccinated chil-
dren there decreased significantly [9]. In a poll conducted by the Harvard School of Public
Health in September 2009, of the adults who said that they did not intend to get the pandemic
influenza vaccine for themselves or their children, 60% also said that they would change their
mind if other members of the community were sick or dying from A(H1N1)pdm2009 [10].
Finally, in a meta-analysis of 34 studies, Brewer and colleagues [11] found that both the
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perceived likelihood of being harmed by a disease and the perceived severity of that harm are
significant predictors of vaccine behavior.
In sum, complacency is a major contributing factor to vaccine hesitancy, but hesitancy can
be overcome by increasing perceived risk (which decreases complacency). What is not well
understood, however, is how change in perceived risk translates into change in vaccine hesi-
tancy. In other words, we do not yet have a sufficiently rich understanding of “vaccine propen-
sity,” a concept introduced by Justwan and colleagues [12] that we further advance here.
We define vaccine propensity as a mapping from perceived risk of infection to reported willing-
ness to vaccinate, holding fixed other considerations, such as vaccine confidence and convenience.
By “perceived risk of infection,” we mean the combination of the probability of contraction and
the severity of the disease, as understood in terms of morbidity and mortality. We see the concept
of vaccine propensity as enriching the concept of vaccine complacency by providing a dynamic
mechanism of how hesitancy may change in response to changes in the landscape of risk.
Strictly speaking, vaccine propensity is an individual attribute and is expected to vary across
individuals. That is, given some information about disease prevalence and severity, individuals
subjectively determine (or “perceive”) their risk of infection. Individuals can then report their
(un)willingness to vaccinate if the perceived risk is above (below) some subjective threshold.
Alternatively, the threshold itself can be probed by asking how much risk someone is willing to
accept (e.g., in terms of disease prevalence) before they are willing to vaccinate (holding fixed
other concrete information about, e.g., disease severity). While vaccine propensity is individual
or subjective, it is helpful to translate it to the aggregate level. This can be done by estimating a
function that outputs the cumulative proportion of a sampled population that reports a will-
ingness to vaccinate for a given level of disease prevalence as input. In this way, the concept of
vaccine propensity can also be understood and illustrated at a population level. This is particu-
larly helpful for epidemiological considerations, wherein we may want to identify subpopula-
tions that are more or less responsive to disease risk. That is, we can look at the increase of the
cumulative proportion of a population that is willing to vaccinate as disease prevalence
increases. In light of these considerations, and given that our analysis emphasizes the popula-
tion level, we will use the phrase “vaccine propensity” to denote the aggregate version.
This paper has 2 goals. The first is to enrich our understanding of the role of complacency
in vaccine hesitancy by determining how changes in vaccine hesitancy are associated with
changes in risk (complacency). We do this by using the concept of vaccine propensity (see Fig
1). To make “risk” more concrete here, we use “number of local cases” as the primary determi-
nant of probability of infection. The second goal of this paper is to determine how vaccine pro-
pensity is associated with sociodemographic factors. It is known that a variety of variables
predict vaccine status or attitude. For example, research shows that vaccination rates vary with
sociodemographic factors such as income, marital status, and age [13–15]. It has also been
shown that, while the average rate of nonmedical exemption has increased from 1.5% to 3%
across more than 6,000 schools in California from 2007 to 2013, there are many schools and
regions with rates between 10% and 20%, and that white children attending private schools
from families with higher incomes tend to have much higher exemption rates [16, 17]. In
Texas, exemptions statewide rose from 10,000 to 45,000 in the 2007–2015 span [18], and of the
14 schools with exemption rates between 15% and 40%, 6 are clustered in the Austin area [19].
Similar vaccine refusal clustering has been documented in Washington State [20] and Michi-
gan [21]. In fact, as of 2018, several “hotspots” of nonmedical exemptions have been docu-
mented across the US and appear to continue to grow [4]. While the true reason for variation
in nonmedical exemptions and vaccination rates is expected to be nuanced and involve cul-
tural dimensions, we can reasonably expect that sociodemographic factors at least roughly
track some of the sources of variation.
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Both theory and empirical evidence indicate that the clustering of susceptible individuals
makes outbreaks more probable [20–25]. It is not known, however, whether sociodemographic
variables are also predictive of changes in vaccine behavior with respect to changes in risk of
infection. If there are differences in vaccine propensity due to differences in sociodemographic
makeup, we do not expect outbreaks to be equally probable, nor equally severe: some regions
may be more responsive to changes in risk than others and thereby decrease the chances of a
regional outbreak and/or decrease the size of an outbreak. Understanding how vaccine pro-
pensity is affected by sociodemographic factors is thus invaluable for predicting where out-
breaks are more likely to occur and their expected size, even with the resulting cascade of
changing vaccination rates and the respective feedback on potential outbreaks.
Furthermore, understanding sociodemographic factors of vaccine propensity would be use-
ful for intervention strategies that make use of targeted messaging. It has been recognized that
the “information deficit model” approach, which proceeds on the basis that vaccine hesitancy
Fig 1. Illustration of vaccine propensity. The source of vaccine hesitancy has 3 components: complacency, confidence, and
convenience. We are interested in understanding how a change in complacency due to a shift in risk—e.g., an increase in
disease prevalence—maps onto a change in vaccine acceptance.
https://doi.org/10.1371/journal.pmed.1003354.g001
PLOS MEDICINE Vaccine propensity in the US
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003354 October 15, 2020 5 / 23
is simply a matter of lack of knowledge, is not sufficient for changing vaccine behavior [26].
One way to improve communication strategies is to incorporate our understanding of the
sociodemographic factors that influence hesitancy.
To help fill these knowledge gaps, we sought to better understand how vaccine hesitancy is
associated with changes in risk (which we call vaccine propensity) and, in turn, how vaccine
propensity is associated with common sociodemographic factors.
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) guideline (S1 STROBE Checklist). Our study did not have a protocol or
prespecified analysis plan with respect to empirically advancing the concept of vaccine propen-
sity. The details of our analyses were decided upon after conducting the survey. Analyses were
not data driven or exploratory—we opted for a model selection approach constrained by all
our explanatory variables. Our knowledge-based model analysis was conducted in response to
a request from a reviewer.
Data collection and sample characteristics
For our statistical analysis, we rely on original micro-level data from a demographically diverse
online survey programmed on Qualtrics (https://www.qualtrics.com). Participants for our
online survey were collected via Survey Sampling International (SSI) (please note that SSI
rebranded as Dynata after our study [https://www.dynata.com]). SSI is a US-based market
research firm that maintains panels of persons used only for research. Panelists voluntarily
join an SSI panel by responding to an online SSI advertisement (e.g., a banner advertisement
on a website). SSI uses invitations of all types, including email invitations, phone alerts, and
banners and messaging on panel community sites to include people with diverse motivations
to take part in research. At the time of enrollment, new panelists are asked to join an online
market research panel. At this point, it is made clear that it is not part of a sales process. Our
survey invitations provide only basic links and information that is nonleading. Panelists are
rewarded for taking part in surveys according to a structured incentive scheme, with the incen-
tive amount offered for a survey determined by the length and content of the survey, the type
of data being collected, the nature of the task, and the sample characteristics. Panelists are sup-
ported by a dedicated team and have the option to unsubscribe at any time. SSI’s panel man-
agement is compliant with market research industry standards, data protection, and privacy
laws.
Our quota sample (rather than a probability sample) includes individuals who were selected
based on several demographic characteristics and resemble the US population according to 5
major dimensions: age, income, sex, race, and census region. Our sample was not designed to
match population characteristics for education, but it still turned out to be relatively close in
that regard. A detailed comparison of sample characteristics and cell percentages from the
2010 census can be found in Table 1.
Survey data were collected from January 25, 2018, to February 2, 2018. A total of 6,597 sur-
vey invitations were sent out by SSI. We had a total of 5,140 respondents that began the survey;
229 respondents discontinued the survey by the first “quality control” check, and another 32
discontinued by the second. The 2 “quality control” checks were the following 2 questions,
respectively. Question 1 read as follows: “For quality control purposes, please select the num-
ber five with the letter ‘G’ next to it.” Answer options were 5A, 5B, 5C, G, 5D, 5E, 5F, 5G, and
5H. Question 2 read as follows: “Research shows that people, when making decisions and
answering questions, prefer not to pay attention and minimize their effort as much as possible.
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Some studies show that over 50% of people don’t carefully read questions. If you are reading
this question and have read all the other questions, please select the box marked ‘other.’ Thank
you for participating and taking the time to read through the questions carefully! What is this
study about?” Answer options were (1) Health, (2) Diseases, (3) Vaccines, and (4) Other. After
deleting individuals who did not pass quality control checks, there were 3,007 valid responses.
The completion rate (CR) for our survey is 58.5% and is based on the following calculation:
the number of respondents who completed the survey divided by the number of those who
began the survey, or CR = 3,007/5,140 = 58.5%.
The survey was structured as follows. First, respondents provided information about the
size of their social network and the places they live in and visit during a typical week. Second,
Table 1. Sample characteristics (compared to 2010 census).
Variable Population (2010 Census) Sample % (N)
Age, y
18–24 13.08% 16.0% (481)
25–34 17.51% 18.2% (547)
35–44 17.51% 18.1% (543)
45–54 19.19% 18.4% (553)
55–64 15.55% 14.5% (435)
65 or older 17.17% 14.9% (446)
Sex
Male 48.53% 47.1% (1,404)
Female 51.47% 52.9% (1,574)
Income (in USD)
Less than $30,000 29.00% 26.4% (792)
$30,000–$49,999 19.00% 20.2% (607)
$50,000–$100,000 30.00% 34.00% (1,023)
$100,000+ 22.00% 19.4% (583)
Race/Ethnicity
Hispanic or Latino 16.30% 14.1% (423)
White 63.70% 76% (2,335)
African American 12.20% 12.2% (395)
Asian 4.70% 4.4% (149)
Region
Northeast 18.00% 18.0% (541)
Midwest 22.00% 22.0% (661)
South 37.00% 37% (1,113)
West 23.00% 23.0% (691)
Education
Less than high school 4.8% 0.4% (13)
High school incomplete 8.9% 2.9% (87)
High school graduate 31.0% 19.9% (598)
Some college, no degree 19.3% 27.0% (812)
Two-year associate’s degree 8.6% 11.2% (337)
Four-year college degree 18.0% 26.5% (798)
Postgraduate/professional degree 9.3% 12.0% (360)
Our survey was designed to match population characteristics for age, sex, income, ethinicity, and region to data from
the 2010 census. We include a comparison for education as well.
https://doi.org/10.1371/journal.pmed.1003354.t001
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participants read a brief description of a hypothetical infectious disease and then were asked a
series of questions about how they would respond to this disease if it broke out in the US. The
survey concluded with a third section in which respondents answered a series of questions
about their political beliefs and basic demographic attributes. The survey questions for the var-
iables in this paper are provided in S1 Text.
Ethics statement
Before launching the survey, we obtained Institutional Review Board (IRB) exemption from
the University of Idaho IRB (Project Number: 18–017; exemption granted under category 2 at
45 Code of Federal Regulations [CFR] 46.101[b][2]). Informed consent was obtained electron-
ically from study participants before they began the online survey.
Dependent variable measurement
Our dependent variable is “vaccine propensity,” which we defined as the extent to which infec-
tion risk translates to a respondent’s self-reported willingness to vaccinate. In order to measure
this concept, we need to ascertain at what level of risk a given respondent would be willing to
get vaccinated against a particular disease, holding other parameters constant. Given that indi-
viduals are likely to vary substantially in their knowledge about and experiences with any “real
world” disease, we opted to rely on a hypothetical scenario.
Survey respondents were told that a new “disease has been discovered within the United
States.” We explained that any person who comes in contact with an infected individual has a
25% chance of contracting the disease. Providing this piece of information allowed us to hold
the perceived infectivity of the condition constant. Next, we described that the disease causes a
number of different symptoms: fever, diarrhea, vomiting, severe stomach pain, headaches and
dizziness. Finally, in order to explore whether the severity of the disease influences vaccine
propensity, we randomized the last bit of information across respondents: we split our sample
into 7 even-sized groups and informed participants about the specific dangers associated with
the infection. One group read that “people who contract the disease are sick for 1–3 days—too
sick to work, go to school, care for others or leave the house.” Three other groups read the
same statement with the exception that the condition would last “4–7 days,” “8–14 days,” or
“more than 15 days.” The final 3 groups were informed that the illness could potentially be
lethal and that it would kill approximately “1 in 1,000 people (0.1%)” who contract it, “1 in 100
people,” or “1 in 10.”
After reading one of these 7 different severity cues, respondents learned that a “highly pro-
tective vaccine (with minimal chances of side effects) is recommended and available” to them
locally at no cost. Subsequently, all respondents answered a survey question that directly taps
into vaccine propensity. In particular, we asked each respondent how many people in his/her
local community would have to get infected with this disease for him/her to get vaccinated.
Answer options were as follows: (1) no one, (2) 1, (3) 10, (4) 100, or (5) other [write in], (6) I
will not vaccinate for this disease, and (7) I do not know. Only 45 answered “other,” 395
answered “I do not know,” and 160 did not answer the question. These individuals were omit-
ted from the following analyses.
Thus, our final dependent variable has 5 distinct categories. Individuals who would vacci-
nate even if “no one” is infected and respondents who would not vaccinate for this disease at
all are both unaffected by infection risk, but they occupy different end points on a spectrum.
Individuals in our middle categories (1, 10, 100) are those survey respondents who display
(varying levels of) sensitivity to infection risk—some of them requiring high numbers of locally
reported cases before they would get vaccinated and some of them reacting to fairly low case
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counts. Our statistical analyses assess the sociodemographic and risk factors that are associated
with when individuals will seek vaccination.
Independent variables, data processing, and analysis
All processing and analysis of the data was performed in R version 3.4.4 [27]. In order to pre-
dict vaccine propensity, we consider sociodemographic characteristics, including race, age,
sex, income, education, population size of a respondent’s hometown, population sizes of all cit-
ies commuted to during a typical week, number of children, age of youngest child (if applica-
ble), political ideology, religious affiliation, religiosity (importance of religion and frequency of
attending religious services), and the self-reported health of the respondent. All of the above
variables were treated as factors with the exception of age, which was treated as a continuous
variable. Some of the factors were treated as ordinal if an obvious ordering relationship exists,
such as for income ranges and population sizes. We also controlled for whether the disease sce-
nario presented to a given survey respondent involved mortality or morbidity. Only respon-
dents who answered all of the questions pertaining to the variables above were included in our
analyses (i.e., if any of the questions was not answered or answered as “unknown,” then the
observation was removed from the sample). The final sample size for analysis was 2,411.
Some of our independent variables were recoded prior to conducting the analyses. This was
done since the case counts in some response categories were very low. The population sizes of
cities commuted to during a week were reduced to the largest city commuted to, which was
categorized (in order) as follows: does not commute, smaller than 1,000, 1,000–50,000,
50,000–250,000, 250,000–1,000,000, or more than 1,000,000. We used number of children and
the age of the youngest child to compute a new variable that reflected whether the respondent
had either no children, children at home (age of youngest child less than 19 years), or adult
children. Political ideology is measured via 7-point Likert scale ranging from very liberal to
very conservative. We omitted from our analyses respondents who identified as either “Liber-
tarian” or “other.” Respondents who identified themselves as either Jewish or Mormon were
coded as “other,” thereby providing us with the following categories for analysis: Protestant,
Catholic, other, and not religious. Income level (originally recorded in US$10,000 intervals)
was recoded as follows: less than $30,000, $30,000–$59,999, $60,000–$90,000, and more than
$90,000. Respondents who answered that they had 1–8 years of education or did not complete
high school were categorized as “no high school diploma”; those who graduated high school
but either did not attend college or did not graduate from college were categorized as having
“high school diploma”; those who either received a bachelor’s degree, an associate’s degree, or
did not complete a graduate/professional degree were treated as “college graduates”; those who
did complete a graduate/professional degree were treated as having “graduate education.”
Race was reduced to 3 categories: black, white, and other. The final number of respondents
used for analysis was 2,411. Descriptive statistics are provided in Table 2.
Analysis of the survey data was conducted in the following manner. Our dependent variable
was whether an individual would choose to get vaccinated (binary yes/no) at a particular risk
level (0, 1, 10, 100 cases, or never). Thus our response variable was binary, and each individual
had 4 repeated observations (one for each risk level less the “never” category). To control for
the repeated observations, we utilized generalized estimating equations (GEEs) to fit a bino-
mial model. We performed model selection in 2 phases: First, step-wise selection based on
quasi-information criterion (QIC) was performed on all explanatory variables. Second, with
the reduced set of explanatory variables, we then searched the model space where all pairwise
interactions were considered (again, based on QIC). Model selection was halted after all
remaining terms had a significance level�0.1. After model selection was completed, P values
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Table 2. Frequency of responses for survey questions that were used for analysis (information for age frequency
can be found using S1 Code).
Question Response Percentage
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for independent variables were determined by ANOVA. In order to test the robustness of our
analysis, we also used a knowledge-driven approach to building models. Our results are similar
across our automatic model selection approach and the knowledge-driven approach. Details
for the latter can be found in S2 Text.
Results
The results of the analysis are presented in Tables 3 and 4. The step-wise model selection pro-
cedure determined that the best model (in terms of QIC) to predict vaccine propensity from
our data used age, sex, political ideology, income, and the consequences of the disease (mortal-
ity versus morbidity); multiple interaction terms—all involving either age or risk (number of
local cases)—were statistically significant.
We did not find significant relationships between vaccine propensity and the following var-
iables (P values reported from knowledge-driven approach, P<0.01 indicates statistical signifi-
cance, see S2 Text for more details): religion (P = 0.21), religious importance (P = 0.82),
frequency of attending religious service (P = 0.8152), hometown size (P = 0.9397), the size of
the largest city commuted to (P = 0.2909), race (P = 0.0209), whether individuals had children
or children at home (P = 0.4771), an individual’s health (P = 0.7275), and the individual’s edu-
cational attainment (P = 0.0168).
Fig 2 illustrates our concept of vaccine propensity and compares the morbidity and mortal-










Frequency of religious service attendance
Never 27
Seldom 24
A few times per year 15
Once or twice per month 9
Once per week 20
More than once per week 7
Importance of religion
Unimportant 20








Of the retained surveys, 58% (N = 2,411) presented mortality as a consequence of infection.
https://doi.org/10.1371/journal.pmed.1003354.t002
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(understood here as the proportion of a population willing to seek vaccination, or “proportion
seeking vaccination” for short) responds to a change in risk in terms of local cases. As risk
increases in terms of the number of local cases of disease, so does the proportion seeking vacci-
nation. In addition, the proportion seeking vaccination tends to be higher in the mortality sce-
nario than the morbidity scenario for each risk level. In both scenarios, it is approximately
40%, a shift from 50% to 90%. That is, the difference between the proportion of the population
willing to seek vaccination when risk is high (100 local cases) is around a 40-percentage-point
increase from when risk is lowest (zero local cases).
Moreover, vaccine propensity appears to be gradual. That is, we do not observe that the
40-percentage-point increase occurs from one level of risk to the next, say from zero to 1 local
Table 3. The resulting GEE model for vaccination propensity by respondent characteristics (N = 2,411).
Degrees of Freedom χ2 P(>|χ|)
Political Leaning 6 19.27 0.0037
Scenario 1 13.52 0.0002
Age 1 21.14 <0.0001
Sex 1 10.72 0.0011
Income 3 22.29 0.0001
Local Cases 3 1,190.05 <0.0001
Political Leaning � Local Cases 18 37.93 0.0040
Scenario � Local Cases 3 6.25 0.1000
Age � Sex 1 3.43 0.0639
Age � Local Cases 3 23.69 <0.0001
Age � Scenario 1 3.56 0.0591
Model selection was done based on QIC, and sandwich error variances were calculated to correct for individual
effects. For the resulting model, pseudo-R2 = 0.135 (see [41]).
Abbreviations: GEE, generalized estimating equation; QIC, quasi-information criterion
https://doi.org/10.1371/journal.pmed.1003354.t003
Table 4. Pairwise comparisons of very liberal, moderate, and very conservative across our 4 levels of risk in terms of local cases (N = 2,411).
Contrast Estimate Standard Error z P(>|z|)
Local Cases = 0
Very liberal–moderate 0.4343 0.1547 2.808 0.0050
Very liberal–very conservative 0.4803 0.1988 2.415 0.0157
Moderate–very conservative 0.0460 0.1667 0.276 0.7827
Local Cases = 1
Very liberal–moderate 0.2611 0.1661 1.572 0.1161
Very liberal–very conservative 0.5855 0.2092 2.798 0.0051
Moderate–very conservative 0.3244 0.1731 1.875 0.0609
Local Cases = 10
Very liberal–moderate 0.2985 0.2028 1.472 0.1411
Very liberal–very conservative 0.8897 0.2410 3.691 0.0002
Moderate–very conservative 0.5912 0.1913 3.091 0.0020
Local Cases = 100
Very liberal–moderate 0.0648 0.2419 0.268 0.7887
Very liberal–very conservative 0.9144 0.2752 3.323 0.0009
Moderate–very conservative 0.8496 0.2189 3.882 0.0001
Results are given on the log odds ratio (not the response) scale.
https://doi.org/10.1371/journal.pmed.1003354.t004
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case. Rather, we observe a more gradual increase over the 4 levels. This suggests that respon-
dents are doing some, albeit rough, mental calculations regarding the probability of getting
infected. And, given that the mortality scenario is higher than the morbidity scenario, this cal-
culation is also taking into consideration the consequences of the disease.
One of the reasons for using the concept of vaccine propensity is to identify whether there
are differential responses to risk levels for different types of populations. That is, we expect that
some populations are more responsive to risk than others and that we would see this by com-
paring their changes in proportion willing to seek vaccination. In terms of our model, this
means identifying sociodemographic variables that significantly interact with the variable we
use to represent risk: number of local cases.
The variable for number of local cases had 2 interactions with sociodemographic variables
(our scenario variable does not count as sociodemographic). The first is with political leaning
(see Fig 3). Results suggest that a smaller proportion of respondents on the conservative end of
the ideology spectrum are willing to seek vaccination than respondents who report being lib-
eral. Specifically, at 0 local cases the proportion of “very conservative” respondents willing to
vaccinate was 0.457 (0.386–0.528), and the proportion of “very liberal” respondents was 0.576
(0.511–0.638). At 100 local cases the proportion of “very conservative” respondents willing to
vaccinate was 0.786 (0.721–0.840), and the proportion of “very liberal” respondents was 0.902
(0.860–0.932). Pairwise comparisons of very liberal, moderate, and very conservative respon-
dents at each risk level can be found in Table 4.
Fig 2. The proportion of respondents willing to seek vaccination given number of local cases of disease for the morbidity and
mortality scenarios. The potential for mortality appears to be more strongly associated with willingness to vaccinate than morbidity.
Zero local cases indicates that respondents are willing to vaccinate even if there are no local cases of the disease (though the disease does
exist in the US). Slight offset in points and dotted lines are for visual aid.
https://doi.org/10.1371/journal.pmed.1003354.g002
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One group that is particularly interesting to notice is “moderate.” When the number of
local cases is zero, we see that the proportion of moderates willing to seek vaccination is 0.468
(0.430–0.507), about as low as those that are conservative 0.430 (0.383–0.479) or very conser-
vative 0.457 (0.386–0.528). When the number of local cases reaches 100, the proportion of
moderates is 0.896 (0.871–0.917), just as high as the others, with the exception of respondents
that are very conservative. In short, when risk is low, moderates respond much like very con-
servatives, but as risk increases moderates respond more and more like very liberals.
The other sociodemographic variable that risk interacted with is age (P<.0001). Fig 4 illus-
trates that risk assessments are being done differently across age groups for different risk levels.
The proportion of younger respondents willing to vaccinate has the most variation, starting
from 0.397 (0.360–0.436), when risk is at its lowest (0 local cases), going up to 0.900 (0.876–
0.919), when risk is highest (100 local cases). As we consider older respondents, this variation
decreases, with 0.653 (0.599–0.704) of the oldest respondents willing to seek vaccination at the
lowest risk level and 0.878 (0.835–0.910) willing at the highest.
The proportion willing to vaccinate in the mortality scenario is nominally higher and less
variable across ages than the morbidity scenario; however, the interaction between age and
scenario did not reach statistical significance (P = 0.0591). Fig 5 illustrates the observed rela-
tionship between age and proportion willing to vaccinate for each scenario. The proportion
willing to vaccinate appears relatively stable across age groups in the mortality scenario.
Fig 3. Comparing ideologies in proportion willing to seek vaccination across 4 levels of risk. Visual inspection suggests a rough trend
that the conservative end of the ideology spectrum has a lower proportion willing to seek vaccination than the liberal end. Exact values
can be found in Table 4. It is noteworthy to compare the very liberal, the very conservative, and the moderate. When risk is lowest at
zero local cases, moderate respondents are similar to conservative and very conservative respondents. When risk is highest at 100 local
cases, moderate respondents are similar to the liberal ends of the spectrum. The moderate population thereby exhibits a higher
responsiveness to changes in risk. The points are offset from 0, 1, 10, and 100 as a visual aid. Whiskers from the points are the 95%
confidence intervals.
https://doi.org/10.1371/journal.pmed.1003354.g003
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Moreover, older people seem to treat the mortality and morbidity scenarios similarly, as the
proportion willing to vaccinate in both are nearly identical. In the morbidity scenario, how-
ever, fewer young people are willing to vaccinate than older people. However, it is important
to note that these differences did not reach statistical significance.
Although the interaction between age and sex approached but did not reach statistical sig-
nificance (P = 0.0639), Fig 6 illustrates our observation that for younger populations, similar
proportions of men and women are willing to vaccinate (0.716 [0.671–0.757] and 0.716
[0.673–0.755], respectively, at 95% CI.) As age increases, a larger proportion of men (0.837
[0.792–0.874]) are willing to seek vaccination than women (0.739 [0.667–0.800]), although
with overlapping confidence intervals. We provide a possible interpretation in the discussion
section.
Finally, family incomes above $90,000 are willing to vaccinate in higher proportion at 0.801
(0.774–0.825) than those with incomes below that (P = 0.0001) (see S2 Text for comparisons in
our knowledge-driven approach). Specifically, the proportion of families with incomes in the
$60,000–$90,000 range was 0.718 (0.682–0.752), in the $30,000–$60,000 range was 0.735
(0.705–0.762), and in the below $30,000 range was 0.717 (0.683–0.750) (see Fig 7).
Discussion
Our study objective was to better understand how vaccine hesitancy is associated with changes
in risk (vaccine propensity) and, in turn, how vaccine propensity is associated with common
Fig 4. For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages. Younger populations vary
more in proportion willing to seek vaccination than older ones, i.e., when risk is lowest (0 local cases) the young have the lowest
proportion, but when risk is highest (100 local cases) the proportion is at least as high for the young as the old. This illustrates a key idea
behind vaccine propensity: some populations are more responsive to changes in risk than others. The solid lines are the trend lines, and
the shaded area is the 95% prediction interval.
https://doi.org/10.1371/journal.pmed.1003354.g004
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sociodemographic factors. To do this, we collected and analyzed original micro-level data
from a demographically diverse online survey.
In brief, we find an overall change of at least 30% in proportion willing to vaccinate as risk
of infection increases, where risk is understood in terms of number of local cases. In addition,
we find that the risk of mortality invokes a larger proportion willing to vaccinate than mere
morbidity, that older populations are more willing than younger, that the highest income
bracket (>$90,000) is more willing than all others, that men are more willing than women,
and that the proportion willing to vaccinate can depend on both ideology and the level of risk.
It is known that changes in risk correspond with changes in rates of vaccination and non-
medical exemptions: decreases in risk can lead to increases in nonmedical exemptions and
lower vaccination rates [16–18, 20, 21], while increases in risk can lead to decreases in non-
medical exemptions and higher vaccination rates [5–11]. Moreover, it is known that vaccina-
tion rates vary with sociodemographic factors such as income, marital status, and age [13–15]
and that vaccine hesitancy also has other sociodemographic determinants [2]. It is not known,
however, how much of a change in risk is required to produce a change in vaccine hesitancy,
nor do we know the sociodemographic variables that moderate these changes. Thus, the goals
of this paper were to empirically advance the concept of vaccine propensity to enrich our
understanding of complacency in vaccine hesitancy and to study the sociodemographic factors
that are associated with vaccine propensity.
With respect to the first goal, we studied several scenarios of severity associated with dis-
ease, 4 ranging in different levels of morbidity and 3 in chances of mortality. For each scenario,
we measured people’s acceptable risk of infection in terms of the number of local cases of
Fig 5. Comparing the morbidity and mortality scenarios across ages. The mortality scenario is relatively stable across ages, while the
morbidity scenario changes. Younger populations are less motivated by morbidity than mortality, but older populations respond
similarly to both scenarios. The solid lines are the trend lines, and the shaded area is the 95% prediction interval.
https://doi.org/10.1371/journal.pmed.1003354.g005
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infections that it would take for someone to get vaccinated. We were able to estimate a vaccine
propensity relationship that started from the number of people that would vaccinate given
zero cases of local infections. As the number of local cases of infection increased from zero to 1
to 10 to 100, the cumulative number of people that would vaccinate increased as well, with
more people being added for lower increases of infection risk (e.g., from zero to 1) than for
higher increases (e.g., from 10 to 100). Somewhat surprisingly, we did not find significant pre-
dictors within either morbidity or mortality individually, i.e., respondents did not seem to be
motivated by, e.g., increases in how long symptoms last or how likely the infection is to cause
mortality. However, we did find a significant difference between the morbidity scenarios and
the mortality scenarios. In the morbidity scenario specifically, we estimated that around 48%
would vaccinate at zero cases, 17% would vaccinate at 1 case, 15% would at 10 cases, and 7% at
100. Moreover, we found that respondents are more motivated by risk of mortality than risk of
morbidity to vaccinate, which we intuitively expect—death is scarier than symptoms of dis-
ease. More specifically, we see the same rising trend in response to increasing risk in the mor-
tality scenario as we saw in the morbidity scenario, but with an addition of about 5% more at
each risk level.
These results give us a first estimate of vaccine propensity that provides a more detailed
understanding of complacency. We can distinguish, e.g., not only between the heights of 2 vac-
cine propensity functions, which tells us which scenario or subpopulation has higher rates of
reported willingness to vaccinate, but also between their slopes, which tells us about respon-
siveness to changes in disease prevalence. The vast majority of people would vaccinate for
higher levels of infection risk (e.g., 100 or 10 cases), but as infection risk declines, so does
Fig 6. Proportion of men versus women willing to seek vaccination across age groups in the morbidity scenario. Men and women
respond similarly when young, but as age increases a larger proportion of men will seek vaccination than women. The solid lines are the
trend lines, and the shaded area is the 95% prediction interval.
https://doi.org/10.1371/journal.pmed.1003354.g006
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intention to vaccinate, with the largest decrease in motivation seen when risk of infection goes
from 1 to zero local cases. Put differently, we expect the largest increase in proportion willing
to vaccinate to be when a single case of the disease first arrives locally, with a diminishing
return as the number of local cases increases.
With respect to the second goal, we were able to identify several sociodemographic factors
that are associated with vaccine propensity, including age, sex, income, and ideology. Given
the extant empirical evidence on the relationship between age and risk [28, 29], we expected to
see that younger populations would be less risk averse than older populations, with older
respondents being more willing to vaccinate. Consistent with the literature, we found that
older populations were more willing to vaccinate in order to mitigate risk of infection. Poten-
tial explanations for this include that older respondents are more likely to be concerned about
mortality from infections and, additionally, are more likely than younger respondents to have
experienced or witnessed diseases. However, the difference between younger and older
respondents is not merely because the young are generally less averse to risk, since at high risk
the young are just as averse. Rather, it seems that the young are more actively assessing risk
against other factors—perhaps convenience—and making a calculated decision.
In terms of sex differences, the literature suggests women to be more risk averse than men
[30]. However, contrary to the general literature on sex and risk, the association between vac-
cine propensity and sex was in the opposite direction in our study, with men being more likely
to vaccinate than women. The only exception is for the youngest respondents, with similarly
lower proportions willing to vaccinate in the 70%–75% range. One possible explanation for the
difference between men and women is as follows. In a disease context, there are 2 risks being
Fig 7. Comparing different levels of income in their proportion to seek vaccination across ages. Populations with family incomes
above $90,000 are significantly greater in their proportion to seek vaccination than others, particularly in the 50-year-old and 60-year-
old age groups. Whiskers from the points are the 95% confidence intervals.
https://doi.org/10.1371/journal.pmed.1003354.g007
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weighed: risk of infection and risk of vaccine side effects. In our study, respondents were told
that there were minimal chances of side effects. However, it is possible that the perceived sever-
ity of side effects is different across sex, with lower perceptions of severity among men and
higher perceptions of severity among women. This explanation is consistent with a recent
study in which women report more adverse effects of vaccination than do men [31]. It is also
possible that men become more risk averse as they get older because their overall mortality
risk is higher than women of the same age and this influences their decision-making.
With respect to income, Sakai [32] found that childhood vaccination rates at the country
level rise and then fall with increases in income, with vaccination rates peaking around a per
capita income of $30,000–$40,000. For the US counties specifically, 4 of the 7 vaccines exam-
ined also showed a peak in vaccination rates for middle-range incomes, with vaccination rates
decreasing as incomes moved toward low and high. Similar results were obtained at the indi-
vidual level, with the probability of a child being up to date on vaccination lower on both low-
and high-income ends for many vaccines. We did not observe such a pattern when it comes to
vaccine propensity: higher levels of income are associated with higher vaccine propensity. The
difference could be that, in our case, we asked respondents to make a decision for themselves,
while Sakai [32] focused on parents making decisions concerning their children. One pur-
ported explanation for why high-income parents have lower vaccination rates for their chil-
dren is that high-income parents feel that they can protect their children through avoidance
measures, thereby limiting their children’s exposure to the threat of disease by reducing risk of
infection [16, 33]. Moreover, higher-income respondents may have perceived the vaccination
option described in our survey to be less costly than engaging in avoidance measures that
would disrupt the routine places they visit (e.g., staying home from work). A second purported
explanation for why childhood vaccination rates decline in high-income populations is that
high-income parents may believe that they have better access to medical technology to treat or
mitigate disease symptoms. Our survey instrument again does not present this as a viable pos-
sibility, since the only technological solution we present to respondents for the new disease is
vaccination. Thus, while we cannot definitely rule out that respondents cannot “buy” mitiga-
tion, we did not encourage such thinking. Both of these purported explanations highlight
health-related affordances made possible by higher levels of income that are alternatives to the
option of getting a vaccination. Since our survey question includes vaccination as the only pos-
sible technological option, it may be tapping into a different pattern. However, since we cannot
effectively test the range of technological options with our survey instrument, we refrain from
drawing a specific explanation.
Given the college wage premium, it is reasonable to expect that the higher vaccine propen-
sity of the>$90 income bracket would also mean a higher vaccine propensity in our education
variable. Education was included in our survey instrument, but we found no significant rela-
tionship between vaccine propensity and education in our analysis. We therefore have reason
to believe that whatever explanations are offered for our finding that the>$90,000 income
bracket has the highest vaccine propensity are unlikely to be related to education.
Arguably our most interesting result pertains to political ideology. Strong conservatives
make up a larger fraction of the vaccine-hesitant population than liberals [34]. Our results are
consistent with these previous findings: the vaccine propensity of very conservative respon-
dents is lower than that of very liberal respondents. Interestingly, however, if we focus on the
slope of the propensity functions, we see a symmetric pattern related to ideology. While there
are more very liberal than very conservative respondents who will vaccinate when there are
zero local cases, increases in infection risk were associated with increased vaccine propensity
for both groups. By contrast, visually the slope was greater among respondents who are moder-
ate or less extreme ideologically, suggesting that they could be more motivated by increasing
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infection risk. This is suggested by noting that when risk is lowest, those who are “middle of
the road” ideologically are among the lowest proportion of those willing to vaccinate, but as
risk increases to the highest level, they are among the highest willing to seek vaccination. This
is consistent with findings that suggest that people with stronger or more extreme ideological
views are less responsive to changes in the world than those with more moderate views [35]. In
brief, the more entrenched or strong a person’s ideological leaning, the more steadfast s/he will
be in their (un)willingness to vaccinate in response to changes in risk. Moderates may be more
pragmatic in their decision-making by focusing more on the risk of contracting the disease
and focusing less on how that decision fits into other aspects of their worldview.
Limitations of our study are as follows. Evidence discussed in the introduction suggests that
an increase in case counts can decrease vaccine hesitancy. Consequently, we focused on how
local case counts were associated with vaccine decisions, holding fixed other considerations.
Nevertheless, it is possible that case counts interact with or differentially weight other consid-
erations that are not captured by our focus on local case counts alone (such as social influence).
Moreover, our survey instrument captured differences between the morbidity and mortality
scenarios but failed to detect significant differences within these categories. We are unable to
say whether this is an artifact of our survey design or whether people’s decision-making is heu-
ristically driven and glosses over degrees in the mortality and morbidity categories. Other limi-
tations concern sample size and representativeness. Our survey design ensured demographic
diversity by matching the US census on age, sex, income, race/ethnicity, and region. After data
collection, we also found that our sample closely matched for the education variable. However,
it is possible that our sample differs from the population in other respects. For example,
because our survey is online, it is unable to capture the part of the US that does not have access
to the internet. We are also not able to capture those who did not complete the survey or failed
our attention checks. Finally, as with any survey, it is possible that responses do not perfectly
reflect actual traits or behaviors. Specifically to us, our survey asked participants to consider a
counterfactual scenario, and it is possible that actual reactions to disease outbreaks would dif-
fer from the predictions that individuals made of themselves.
Our findings have important connections to epidemiological modeling and public health
interventions. A wealth of work is being done in recognition that there is feedback between
changes in human behavior in response to disease and the spread of disease [36–40]. By
improving our understanding of how a change in risk of contracting a disease relates to a
change in willingness to seek vaccination, we can improve epidemiological models often used
to inform public health interventions. More specifically, we have advanced our understanding
by (i) quantifying how different degrees of risk (in terms of local cases of disease) correspond
with different proportions of populations willing to vaccinate and (ii) uncovering how those
proportions will reflect populations that differ across sociodemographic variables, particularly
those related to age, sex, income, and political ideology.
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